Brown Miller Wealth Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.71M Buy
18,710
+1,718
+10% +$370K 1.19% 19
2026
Q1
$3.7M Buy
16,992
+940
+6% +$209K 1.05% 21
2025
Q4
$3.67M Buy
16,052
+259
+2% +$59K 1.01% 22
2025
Q3
$3.66M Sell
15,793
-524
-3% -$107K 1.04% 22
2025
Q2
$3.03M Sell
16,317
-45
-0.3% -$8.36K 0.94% 25
2025
Q1
$3.43M Buy
16,362
+232
+1% +$45.1K 1.19% 20
2024
Q4
$2.87M Sell
16,130
-261
-2% -$48K 1.1% 27
2024
Q3
$3.24M Buy
16,391
+17
+0.1% +$3.17K 1.26% 20
2024
Q2
$2.81M Buy
16,374
+106
+0.7% +$17.6K 1.17% 22
2024
Q1
$2.96M Buy
16,268
+36
+0.2% +$6.2K 1.31% 20
2023
Q4
$2.52M Sell
16,232
-10
-0.1% -$1.46K 1.26% 24
2023
Q3
$2.42M Buy
16,242
+419
+3% +$61.5K 1.35% 19
2023
Q2
$2.13M Sell
15,823
-245
-2% -$35.9K 1.15% 26
2023
Q1
$2.56M Sell
16,068
-2
-0% -$306 1.52% 15
2022
Q4
$2.6M Sell
16,070
-45
-0.3% -$6.9K 1.64% 14
2022
Q3
$2.16M Sell
16,115
-169
-1% -$24.3K 1.53% 18
2022
Q2
$2.49M Sell
16,284
-1,074
-6% -$164K 1.7% 14
2022
Q1
$2.81M Sell
17,358
-165
-0.9% -$24K 1.63% 18
2021
Q4
$2.37M Buy
17,523
+816
+5% +$96.4K 1.36% 24
2021
Q3
$1.8M Buy
16,707
+315
+2% +$36K 1.13% 26
2021
Q2
$1.85M Buy
16,392
+13
+0.1% +$1.46K 1.18% 24
2021
Q1
$1.77M Buy
16,379
+647
+4% +$69.2K 1.25% 25
2020
Q4
$1.69M Buy
+15,732
New +$1.51M 1.27% 24

Other funds holding ABBV

Brown Miller Wealth Management's ABBV Position: Q2 2026 in Review

Brown Miller Wealth Management increased its AbbVie (ABBV) stake by 10% in Q2 2026, buying an estimated $370K and bringing the position to 18,710 shares worth $4.71M. The position accounts for 1.19% of the portfolio, ranked #19.

Brown Miller Wealth Management first reported a position in ABBV in Q4 2020 and has held it in 23 quarters since. 1,476 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Brown Miller Wealth Management held 18,710 shares of AbbVie worth $4.71M as of Q2 2026.
  • Brown Miller Wealth Management bought 1,718 AbbVie shares in Q2 2026, an estimated $370K.
  • AbbVie made up 1.19% of Brown Miller Wealth Management's portfolio in Q2 2026, its #19 holding.
  • Brown Miller Wealth Management first reported a position in AbbVie in Q4 2020 and has held it in 23 quarters since.
  • 1,476 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Brown Miller Wealth Management's 13F filing for Q2 2026, filed 16 Jul 2026.